Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy
Abstract The cGAS-STING signaling pathway has emerged as a critical mediator of innate immune responses, playing a crucial role in improving antitumor immunity through immune effector responses. Targeting the cGAS-STING pathway holds promise for overcoming immunosuppressive tumor microenvironments (...
Main Authors: | Xi Chen, Zhijie Xu, Tongfei Li, Abhimanyu Thakur, Yu Wen, Kui Zhang, Yuanhong Liu, Qiuju Liang, Wangrui Liu, Jiang-Jiang Qin, Yuanliang Yan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-01-01
|
Series: | Biomarker Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40364-023-00551-z |
Similar Items
-
Activation of Stimulation of Interferon Genes (STING) Signal and Cancer Immunotherapy
by: Kewang Luo, et al.
Published: (2022-07-01) -
Clinical applications of STING agonists in cancer immunotherapy: current progress and future prospects
by: Bin Wang, et al.
Published: (2024-10-01) -
Agonists and Inhibitors of the cGAS-STING Pathway
by: Xiaoxuan Yu, et al.
Published: (2024-06-01) -
cGAS‐STING signaling in cancer: Regulation and therapeutic targeting
by: Xinzou Fan, et al.
Published: (2023-09-01) -
Emerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies
by: Jiawen Zhang, et al.
Published: (2024-01-01)